ORGS · As filed with the SEC
Orgenesis cash flow statement, by quarter
The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 | Q3 2023† 3 months ended Sep 30, 2023 | Q2 2023† 3 months ended Jun 30, 2023 | Q1 2023 3 months ended Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Profit or Loss | (20,376)† | (9,266)† | (9,366)† | (10,005) | (6,623)† | 33,995† | 15,455† | (4,261) |
| Adjustments required to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-Based Compensation Expense | 639† | 1,619† | 624† | 312 | 76† | 76† | 152† | 159 |
| Convertible loans induced conversion expenses | 0† | 0† | — | — | — | — | — | — |
| Capital gain, net | (1,714)† | — | — | — | — | — | — | — |
| Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023) | (4,546)† | 0† | 0† | 66 | 0† | (5,754)† | — | — |
| Share in losses (income) of associated companies, net | — | — | — | — | — | — | (3)† | 2 |
| Share in loss of associated companies, net | — | — | — | — | 182† | 553† | (3)† | — |
| Depreciation Expense | 461† | 538† | 706† | 381 | 194† | 191† | 597† | 578 |
| Credit loss on convertible loan receivable | — | — | — | — | 0† | 0† | 0† | — |
| Credit loss net related to OBI, Korea and Belgium subsidiaries | 0† | 0† | 0† | 2,049 | — | — | — | — |
| Amortization of Intangibles | 17,646† | — | — | — | — | — | — | — |
| Effect of exchange differences on inter-company balances | 775† | 1,720† | 152† | (200) | 121† | (85)† | 58† | 191 |
| Net changes in operating leases | 1,547† | 17† | 32† | (8) | 32† | (15)† | (20)† | (47) |
| Interest expenses accrued on loans and convertible loans | — | — | — | — | — | 543† | 537† | (311) |
| Change in Contingent consideration | (4,906)† | 81† | — | — | — | — | — | — |
| Interest expense accrued on loans and convertible loans | 172† | 174† | 555† | 637 | 628† | 580† | 574† | — |
| Loss from extinguishment in connection with convertible loan restructuring | 5,281† | 0† | 0† | 141 | 0† | 0† | 0† | 283 |
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 121† | 79† | 4† | (74) | (19)† | (38,220)† | (22,801)† | (1,613) |
| Prepaid expenses, other accounts receivable | 921† | (251)† | 154† | 1,438 | 2,030† | 259† | 326† | (2,183) |
| Inventory | 0† | 0† | — | — | 0† | 0† | (379)† | (10) |
| Other assets | — | — | — | — | — | 6† | 2† | 2 |
| Other assets | 47† | (3)† | 0† | (1) | 3† | 6† | 2† | — |
| Related parties, net | (4)† | 3† | — | — | — | — | — | — |
| Accounts payable | 672† | 515† | (2,968)† | 502 | 1,591† | 1,034† | 2,950† | (59) |
| Change in Accrued Liabilities | 26† | (858)† | (430)† | 442 | 747† | 21† | 221† | 69 |
| Change in Accrued Liabilities | 1,132† | 176† | 111† | (119) | 276† | 12† | 225† | 2 |
| Change in Deferred Revenue | — | — | — | — | — | — | 0† | 36 |
| Change in advance payments and receivables on account of grant, net | — | — | — | — | — | — | (59)† | (81) |
| Deferred taxes, net | 0† | 0† | 0† | (2) | 0† | 0† | 6† | 3 |
| Net cash used in operating activities | (2,098)† | (4,630)† | (5,907)† | (4,441) | (502)† | (1,181)† | (5,914)† | (7,240) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property, plants and equipment | 0† | (58)† | (1)† | (204) | 0† | (300)† | (511)† | (1,285) |
| Investment in associated company | — | — | — | — | (117)† | — | — | — |
| Net Cash from Investing Activities | 0† | 0† | 0† | 139 | — | — | — | — |
| Impact to cash resulting from deconsolidation of OBI, Korea and Belgium subsidiaries (see note 20) | (6)† | 0† | 0† | (5) | 0† | 0† | — | — |
| Impact to cash resulting from deconsolidation | — | — | — | — | 0† | 0† | — | — |
| Investment in long-term deposits | — | 200† | 0† | 2 | 0† | 0† | (11)† | (22) |
| Net cash used in investing activities | 292† | 142† | (1)† | (68) | (62)† | (843)† | (1,495)† | (1,307) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Proceeds from issuance of shares due to exercise of options and warrants (net of transaction costs) | 0† | 28† | 168† | 2,360 | 942† | 1,000† | (100)† | 3,441 |
| Proceeds from Debt Issuance | 0† | 0† | 0† | 75 | 75† | 175† | 0† | 5,485 |
| Proceeds from Stock Issuance | — | — | — | — | 0† | 0† | — | — |
| Proceeds from receipts on account of shares to be allotted | — | — | — | 155 | — | — | — | — |
| Proceeds from transaction with redeemable non-controlling interest that do not result in a loss of control | — | — | — | — | 0† | 0† | — | — |
| Repayment of convertible loans and convertible bonds | — | — | — | — | 0† | 0† | 0† | (3,000) |
| Repayment of short and long-term debt | 25† | (106)† | (112)† | (33) | (2)† | (3)† | (14)† | (16) |
| Proceeds from issuance of loans payable | 1,390† | 3,723† | 640† | 307 | 210† | — | — | — |
| Receipt from Germfree (see note 11a) | — | — | 5,970† | 750 | — | — | — | — |
| Proceeds from Debt Issuance | (16)† | — | — | — | — | — | — | — |
| Receipt from Germfree (see note 13f) | 0† | — | — | — | — | — | — | — |
| Net cash provided by financing activities | 1,399† | 4,435† | 6,511† | 3,614 | 1,225† | 1,597† | 4,886† | 5,910 |
| NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | (407)† | (53)† | 603† | (895) | 661† | (427)† | (2,523)† | (2,637) |
| Effect of Exchange Rate on Cash | (28)† | 19† | (12)† | (19) | 29† | (11)† | 19† | (1) |
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF YEAR | 1,122 | 1,156 | 565 | 1,479 | 789 | 1,227 | 3,731 | 6,369 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR | 687 | 1,122 | 1,156 | 565 | 1,479 | 789 | 1,227 | 3,731 |
| SUPPLEMENTAL NON-CASH FINANCING AND INVESTING ACTIVITIES | ||||||||
| Exchange of convertible loans for equity | — | 0† | — | — | — | — | — | — |
| Net Cash from Operating Activities | 0† | 214† | — | — | 0† | (1)† | 0† | 753 |
| Increase (decrease) in accounts payable related to purchase of property, plant and equipment | — | — | — | — | 0† | 0† | 0† | 14 |
| Extinguishment in connection with convertible loan restructuring | — | — | — | 141 | 0† | 0† | 0† | 287 |
| CASH PAID DURING THE YEAR FOR: | ||||||||
| Interest Expense | 0† | 0† | — | — | 0† | 0† | 0† | 785 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.